University of Illinois College of Medicine at Rockford — Rockford, Illinois

University of Illinois College of Medicine at Rockford is a clinical research site located in Rockford, Illinois, United States 61107.

Crixeo Clinical Trials Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Illinois College of Medicine at Rockford has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Huntington's Disease, DNA Damage.

Sponsors: CHDI Foundation, Inc., Tahitian Noni International, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rockford

Browse all research sites in Illinois · View every site in Rockford

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Illinois College of Medicine at Rockford?

University of Illinois College of Medicine at Rockford has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Illinois College of Medicine at Rockford conducted?

University of Illinois College of Medicine at Rockford has 2 clinical trials on record, with 1 currently active. Their work covers Huntington's Disease, DNA Damage.

Is University of Illinois College of Medicine at Rockford accredited by Crixeo Clinical Trials?

University of Illinois College of Medicine at Rockford has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Illinois College of Medicine at Rockford?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.